跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDIMMUN NEORAL CAP 10MG - PPB Drug Approval Details
Approvals
/
PPB
/
SANDIMMUN NEORAL CAP 10MG
Approved
STANDARD
SANDIMMUN NEORAL CAP 10MG
NOVARTIS PHARMACEUTICALS (HK) LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
e8a49cc1ba6787bc
Company
NOVARTIS PHARMACEUTICALS (HK) LIMITED
Type
Standard
Approval Details
Approval Id
e8a49cc1ba6787bc
Product Name
SANDIMMUN NEORAL CAP 10MG
Drug Hk Name
SANDIMMUN NEORAL CAP 10MG
Registration Code
HK-51354
Company Name
NOVARTIS PHARMACEUTICALS (HK) LIMITED
Company Detail Path
/organization/novartis-pharmaceuticals-hk-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2003-08-19
Company Address
SUITES 2303-2308, 23/F, NO.1111, KING'S ROAD, TAI KOO SHING, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
e8a49cc1ba6787bc
Type
Standard
Back to PPB Approvals